Genetic Deletion and Pharmacological Inhibition of Nogo-66 Receptor Impairs Cognitive Outcome After Traumatic Brain Injury in Mice

Journal of Neurotrauma- United States

doi 10.1089/neu.2009.1255

Full Text

Abstract

Available in

Categories

Date

July 1, 2010

Authors

Fredrik Clausen

Kristine Jansson

Lars N.G. Nilsson

Paul H. Weinreb

Tracy K. McIntosh

David A. Gimbel

Stephen M. Strittmatter

Niklas Marklund

Publisher

Mary Ann Liebert Inc

Related search

Outcome Assessment After Traumatic Brain Injury

The Lancet Neurology

Danish

Genetic Disruption of Cyclooxygenase-2 Does Not Improve Histological or Behavioral Outcome After Traumatic Brain Injury in Mice

Journal of Neuroscience Research

Molecular Neuroscience

English

Traumatic Brain Injury Decreases AMP-activated Protein Kinase Activity and Pharmacological Enhancement of Its Activity Improves Cognitive Outcome

Journal of Neurochemistry

Molecular Neuroscience

English

Nogo-A and Nogo-66 Receptor in Amyotrophic Lateral Sclerosis

Journal of Cellular and Molecular Medicine

Molecular Medicine

English

Retrospective Assessment of Rehabilitation Outcome After Traumatic Brain Injury

Journal of Head Trauma Rehabilitation

Physical Therapy

English

TNF Alpha and Fas Mediate Tissue Damage and Functional Outcome After Traumatic Brain Injury in Mice

Journal of Cerebral Blood Flow and Metabolism

Cardiovascular Medicine

English

Inhibition of miR-155 Limits Neuroinflammation and Improves Functional Recovery After Experimental Traumatic Brain Injury in Mice

Neurotherapeutics

English

Inhibition of Elevated Hippocampal CD24 Reduces Neurogenesis in Mice With Traumatic Brain Injury

Journal of Surgical Research

English

Combined Blockade of Interleukin-1 Α and Β Signaling Protects Mice From Cognitive Dysfunction After Traumatic Brain Injury

English